5WA — OUE Healthcare Income Statement
0.000.00%
Last trade - 00:00
- SG$128.85m
- SG$1.08bn
- SG$159.32m
- 20
- 81
- 60
- 55
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 19.6 | 20 | 19.7 | 120 | 159 |
Cost of Revenue | |||||
Gross Profit | 14.5 | 15.2 | 14.6 | 102 | 122 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 12 | 78.2 | -79.7 | 48.7 | 56.9 |
Operating Profit | 7.66 | -58.2 | 99.4 | 71.1 | 102 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 5.75 | -102 | 108 | 49.7 | 74.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | 3.24 | -99.2 | 111 | 32.5 | 57.5 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 3.36 | -98.7 | 111 | 4.39 | 8.05 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 3.36 | -98.7 | 111 | 4.39 | 8.05 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.001 | -0.017 | 0.017 | 0.001 | 0.001 |